What Palantir’s £330 million NHS data contract means for patients, privacy and the future of healthcare data in the UK.
A formal appeal has been lodged with the NHS spending watchdog following its decision to withdraw a potentially life-saving cancer treatment from health services across England and Wales. Tecartus, a ...
Hosted on MSN
Why raising NHS spending on new drugs by 25% is the wrong decision – health economist’s view
For nearly three decades, decisions about which medicines the NHS pays for have not been made by ministers, but by the National Institute for Health and Care Excellence, known as Nice. Its job has ...
Some hospital trusts tell the BBC previous action has seen shorter waits, faster decisions and calmer corridors.
Patients in English hospitals now have the right to a second opinion. Scots deserve the same, writes Michaela Guthrie ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results